Dr Kevin Dolan

Laparoscopic Obesity Surgeon

Undergraduate Education

  • 1985 – 1988 St Andrews University, BSc
  • 1988 – 1991 University of Manchester, MB ChB

Qualifications

  • Bachelor of Science (BSc) St Andrews University 1988
  • Bachelor of Medicine, Bachelor of Surgery (MB ChB) University of Manchester 1991
  • Fellow of the Royal College of Physicians and Surgeons of Glasgow (FRCPS) 1995
  • Fellow of the Royal College of Surgeons of Edinburgh (FRCS) 1995
  • Doctor of Medicine (MD) University of Manchester 1999
  • Intercollegiate Subspecialty Examination (FRCS, Upper GI) 2001
  • Fellow of the Royal Australasian College of Surgeons (FRACS) 2004

Professional Society Memberships

  • International Federation of Surgery for Obesity (IFSO)
  • Association of Surgeons of Great Britain and Ireland
  • Association of Upper GI Surgeons
  • International Gastric Cancer Association
  • International Society for Diseases of the Oesophagus
  • Obesity Surgery Society of Australia and New Zealand (OSSANZ)
  • Society for Surgery of the Alimentary Tract

Major Interests

Dr Dolan’s major clinical interest is laparoscopic treatment of obesity. Dr Dolan also performs abdominoplasty, brachioplasty and thighplasty for patients who have lost weight.

Click on the below links to know more about Dr Kevin Dolan.

Current Positions

  • Visiting Surgeon, Hollywood Hospital, Nedlands
  • Visiting Surgeon, Mercy Hospital, Mount Lawley
  • Visiting Surgeon, St John of God Hospital, Subiaco
  • Senior Lecturer, Department of Surgery, University of Western Australia
  • Visiting Surgeon, Glengarry Hospital, Duncraig

Prizes and Awards

  • “Allelotype of Barrett’s adenocarcinoma; a search for novel tumour suppressor genes”
    Surgeon-in-Training Prize finalist, Scientific Meeting, RCS of Edinburgh, May 1996
  • “A new classification of oesophageal and gastric cancer based on changing incidence and clinical features”
    Research Prize Finalist, Liverpool and Northwest Society of Surgery, Chester, Nov 1996
    Zeneca Registrar Prize Finalist, Manchester Medical Society, Manchester, March 1997
  • “Loss of heterozygosity on chromosome 17p predicts carcinogenesis progression in patients with Barrett’s oesophagus”
    North of England Gastroenterology Society Research Prize Winner 1998
    Astra-Association of Surgeons in Training Research Prize Winner 1998
  • EEC Travelling Fellowship Award 1998
    European School of Oncology, Milan

Publications – Obesity related

  • “Laparoscopic gastric banding for morbidly obese adolescents” Dolan K, Creighton L, Hopkins G, Fielding GAObesity Surgery 2003, 13, 101-104
  • “Treating diabetes in the morbidly obese by gastric banding” Dolan K, Bryant R, Fielding GAObesity Surgery 2003, 13, 439-443
  • “Vitamin A deficiency following pancreatico-biliary diversion” Hatzifotis M, Dolan K, Fielding GAObesity Surgery 2003, 13, 655-657
  • “Laparoscopic gastric banding and Crural Repair in Obese Patients with a Hiatus Hernia” Dolan K, Finch R, Fielding GAObesity Surgery 2003, 13, 772-775
  • “Calcium and vitamin D depletion and elevated parathyroid hormone following pancreatico-biliary diversion” Newbury L, Dolan K, Hatzifotis M, Lowe N, Fielding GA
    Obesity Surgery2003, 13, 893-895
  • “Bilio-Pancreatic Diversion Following Failure of Laparoscopic Adjustable Gastric Banding” Dolan K, Fielding GASurgical Endoscopy 2004, 18, 60-63
  • “A comparison of laparoscopic adjustable gastric banding and Biliopancreatic diversion in super obesity” Dolan K, Hatzifotis M, Newbury L, Lowe N, Fielding GA
    Obesity Surgery2004, 14, 165-169
  • “A Comparison of Laparoscopic Adjustable Gastric Banding in Adolescents and Adults” Dolan K, Fielding GASurgical Endoscopy 2004, 18, 45-47
  • “Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery” Slater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, Dolan K, Fielding GAJournal of Gastrointestinal Surgery 2004, 8, 48-55
  • “A nutritional and weight loss comparison between pancreatico-biliary diversion and duodenal switch” Dolan K, Hatzifotis M, Newbury L, Lowe N, Fielding GAAnnals of Surgery 2004, 240, 51-56

Other Publications

  • “Adenocarcinoma of the lower oesophagus and gastric cardia are similar both epidemiologically and clinically; a population based study from 1974 to 1993″ Dolan K, Walker SJ, Sutton R, Williams EMI
  • Progress in Gastric Cancer Research, Siewert J.R. & Roder J.D., Monduzzi Editore Bologna, 1997, 43-44
  • “Microsatellite instability is rarely detected in oesophageal adenocarcinoma” Dolan K, Garde J, Walker SJ, Sutton R, Field JKOncology Reports 1997, 4; 1319-1322
  • “Colo-colonic intussusception due to colonic lipoma” Dolan K, Khan SA, Goldring JRJournal of the Royal Society of Medicine 1998, 91; 94
  • “Allelotype analysis of oesophageal adenocarcinomas; loss of heterozygosity occurs at multiple sites” Dolan K, Garde J, Gosney JR, Sissons M, Wright T, Kingsnorth AN, Walker SJ, Sutton R, Meltzer SJ, Field JKBritish Journal of Cancer 1998, 78; 950-957
  • “Multiple target sites of allelic imbalance on chromosome 17 in Barrett’s oesophageal cancer” Dunn J, Dolan K, Gosney JR, Sutton R, Meltzer SJ, Field JK
    Oncogene1999, 18, 987-993
  • “New classification of oesophageal and gastric carcinoma derived from changing patterns in epidemiology” Dolan K, Walker SJ, Sutton R, Morris AI, Campbell F, Williams EMI
    British Journal of Cancer1999, 80, 834-842
  • “LOH at APC, TP53 and DCC occurs in Barrett’s metaplasia and dysplasia adjacent to adenocarcinoma of the oesophagus” Dolan K, Garde J, Walker SJ, Sutton R, Gosney JR, Field JKHuman Pathology 1999, 30, 1508-1514
  • “Histological and molecular mapping of adenocarcinoma of the oesophagus and gastroesophageal junction: loss of heterozygosity occurs in histologically normal epithelium in the oesophagus and stomach” Dolan K, Walker SJ, Sutton R, Gosney JR, Field JKOncology Reports 2000, 7, 521-528
  • “The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett’s adenocarcinoma involves a unique combination of target sites in individual specimens” Dunn J, Garde J, Dolan K, Gosney JR, Oates BC, Watson AJM, Fielding P, Field JKClin Can Res 2000, 6, 4033-4042
  • “Does pneumatic dilatation affect the outcome of laparoscopic cardiomyotomy?” Dolan K, Zafirellis K, Fountolakis A, Martin IG, Dexter SPL, Larvin M, McMahon MJ
    Surgical Endoscopy2002, 16, 84-87
  • “Multivariate analysis of clinical, operative and pathological features of esophageal cancer:who needs adjuvant treatment?” Zafirellis K, Dolan K, Fountoulakis A, Dexter SPL, Martin IG, Sue-Ling HMDiseases of the Esophagus 2002, 15, 155-159
  • “Evaluation of POSSUM in patients with oesophageal cancer undergoing resection” Zafirellis K, Fountoulakis A, Dolan K, Dexter SPL, Martin IG, Sue-Ling HM
    British Journal of Surgery2002, 89, 1150-1155
  • “TP53 mutations in malignant and premalignant Barrett’s esophagus” Dolan K, Walker SJ, Gosney JR, Field JK, Sutton RDiseases of the Esophagus 2003, 16, 83-89
  • “Proximal gastric exclusion for unresectable carcinoma of the distal stomach” Dolan K, Sue-Ling HMAustralian and New Zealand Journal of Surgery 2003, 73, 929-931
  • “Three different subsite classification systems for carcinomas in the proximity of the GOJ but is it all one disease?” Dolan K, Morris AI, Gosney JR, Field JK, Sutton R
    Journal of Gastroenterology and Hepatology2004, 19, 24-30
  • “Effect of surveillance of Barrett’s oesophagus on the clinical outcome of oesophageal cancer” Fountoulakis A, Zafirellis K, Dolan K, Dexter SPL, Martin IG, Sue-Ling HM
    Br J Surg2004, 91, 997-1003